España
Acceder
Cotización de Arrowhead Pharmaceuticals, Inc. (ARWR) hoy en tiempo real
Análisis técnico y gráfico histórico de Arrowhead Pharmaceuticals, Inc.
Análisis fundamental y estadísticas clave de Arrowhead Pharmaceuticals, Inc.
Ficha de Arrowhead Pharmaceuticals, Inc. (ARWR)
| Ticker | ARWR |
|---|---|
| ISIN | US04280A1007 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Análisis financiero de Arrowhead Pharmaceuticals, Inc.
Resumen financiero e información corporativa de Arrowhead Pharmaceuticals, Inc.
Ratios de valoración: PER, EV/EBITDA y métricas de Arrowhead Pharmaceuticals, Inc.
Márgenes de rentabilidad y Cash Flow de Arrowhead Pharmaceuticals, Inc.
BPA, Dividendos y Valor Contable: Métricas por acción de Arrowhead Pharmaceuticals, Inc.
Solvencia y deuda: Análisis del balance de Arrowhead Pharmaceuticals, Inc.
Ratios de liquidez y Test Ácido: Capacidad de pago de Arrowhead Pharmaceuticals, Inc.
Invertir en Arrowhead Pharmaceuticals, Inc. en 2026: Preguntas frecuentes
¿Qué es Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in Phase 2b clinical trial to reduce production of ...
¿En qué sector opera Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. opera en el sector Healthcare, industria Biotechnology.